Article has no nextliveshere tags assigned

Article has no topics tags assigned

Article has no colleges tags assigned

Description is empty

Article has no audiences tags assigned

Article has no units tags assigned

Contacts are empty

These messages will display in edit mode only.

Medscape: AFIRE encourages less antiplatelet use with novel oral anticoagulant for atrial fibrillation treatment

UC cardiologist weighs in on trial looking at therapies for heart patients

Medscape turned to the expertise of Richard Becker, MD, Director, UC Heart, Lung and Vascular Institute, when reporting the results of a randomized trial comparing an oral anticoagulation with an antiplatelet agent versus an oral anticoagulation alone in patients with both atrial fibrillation and stable coronary artery disease. Becker, also director of the UC Division of Cardiovascular Health and Disease in the College of Medicine and a UC Health cardiologist, authored a New England Journal of Medicine editorial on the results of the AFIRE trial. 

 
 
 
photo of Richard Becker, MD

Richard Becker, MD

Becker is also a spokesman for the American Heart Association.

Read more at Medscape.